Early FDG PET/CT Imaging as a Measure of Response in Patients With Non-Hodgkin Lymphoma on Lenalidomide
Clinical trial NCT03065790 · TERMINATED
Trial details
- NCT number
- NCT03065790
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2017-02-06
- Primary completion
- 2021-04-28
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.